Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cardiotoxicity × Carvedilol × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Heart Failure 1 Cardiotoxicity 1 Cardiomyopathies 1 Breast Neoplasms 1

Interventions

oblimersen 1 Razoxane 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Exercise 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Carvedilol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04023110 2025-10-09

CCTGuide Pilot

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

68 enrolled 20 charts

Breast Neoplasms, Heart Failure, Cardiomyopathies, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡